Literature DB >> 3829054

Recruitment of exogenous macrophages into metastases at different stages of tumor growth.

P J Bugelski, R Kirsh, C Buscarino, S P Corwin, G Poste.   

Abstract

The endogenous tumor-associated macrophage content and recruitment of labeled peritoneal exudate cells into experimental murine B16 melanoma metastases has been examined at different stages in the progressive growth of metastatic lesions. The recruitment of thioglycollate-elicited peritoneal exudate cells and peritoneal exudate cells activated in vitro with muramyl dipeptide was studied. Tumor-associated macrophages and labeled peritoneal exudate cells were identified in paraffin sections by specific histochemical staining and their density in individual metastases measured morphometrically. The density of tumor-associated macrophages and exogenously recruited peritoneal exudate cells was high in very small lesions but decreased rapidly as a function of enlargement of metastases, MD:An; where MD is macrophage density, A is the cross-sectional area of the lesion and n is a negative number. No significant difference was observed in the recruitment of activated and nonactivated peritoneal exudate cells. These results suggest that decreased recruitment of macrophages from the circulation may explain the decrease in the density of tumor-associated macrophages as metastases grow and indicate that macrophage activation is not accompanied by enhanced localization and/or uptake of macrophages into metastases.

Entities:  

Mesh:

Year:  1987        PMID: 3829054     DOI: 10.1007/bf00205584

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

1.  Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers.

Authors:  G W Wood; K A Gollahon
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

2.  Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

Authors:  J B Hibbs
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

3.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

4.  New histochemical method for measuring intratumoral macrophages and macrophage recruitment into experimental metastases.

Authors:  P J Bugelski; R L Kirsh; G Poste
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

5.  A quantitative evaluation of pulmonary macrophage kinetics.

Authors:  A Blussé van Oud Alblas; H Mattie; R van Furth
Journal:  Cell Tissue Kinet       Date:  1983-05

6.  In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.

Authors:  S Sone; I J Fidler
Journal:  Cell Immunol       Date:  1981-01-01       Impact factor: 4.868

7.  Changes in the macrophage content of lung metastases at different stages in tumor growth.

Authors:  P J Bugelski; R L Kirsh; J M Sowinski; G Poste
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

8.  Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.

Authors:  I J Fidler; Z Barnes; W E Fogler; R Kirsh; P Bugelski; G Poste
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

9.  Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents.

Authors:  E Gorelik; R H Wiltrout; D Copeland; R B Herberman
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.

Authors:  S D Deodhar; K James; T Chiang; M Edinger; B P Barna
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

View more
  5 in total

Review 1.  Macrophages and cancer.

Authors:  P W Whitworth; C C Pak; J Esgro; E S Kleinerman; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

2.  Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice.

Authors:  Arif Khan; Aijaz A Khan; Varun Dwivedi; Manzoor G Ahmad; Seema Hakeem; Mohammad Owais
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

3.  Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.

Authors:  M P Tas; P J Simons; F J Balm; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  Different patterns of macrophage infiltration into allogeneic-murine and xenogeneic-human neoplasms growing in nude mice.

Authors:  C D Bucana; A Fabra; R Sanchez; I J Fidler
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

Review 5.  Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow.

Authors:  Robert Wieder
Journal:  Cancers (Basel)       Date:  2022-07-09       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.